Antibiotic Regimen for Infected Wounds on Wound VAC

Initial Assessment and Antibiotic Selection

The Infectious Diseases Society of America recommends assessing for systemic signs of infection, including temperature >38.5°C, heart rate >110 beats/minute, or erythema extending >5 cm beyond wound margins 3, 2
Evaluate for signs of necrotizing infection requiring surgical consultation, such as rapidly spreading erythema, crepitus, or systemic toxicity 2
Obtain appropriate wound cultures before starting antibiotics by tissue sampling from the base of the debrided wound 4

For severe infections, the recommended empiric antibiotic regimen is vancomycin or linezolid plus piperacillin-tazobactam, providing coverage against MRSA, gram-negative organisms, and anaerobes 1, 2
Alternative regimen for severe infections: vancomycin plus ceftriaxone and metronidazole 1
For moderate infections, consider piperacillin-tazobactam or amoxicillin-clavulanate, and add MRSA coverage if risk factors are present 1, 4

For surgical site infections following intestinal or genitourinary surgery, use piperacillin-tazobactam or ceftriaxone plus metronidazole 1
Consider anatomic location when selecting antibiotics, with wounds near perineum or GI tract requiring better anaerobic coverage 3, 2
For diabetic foot infections on VAC, use piperacillin-tazobactam or ertapenem for moderate to severe infections 4

Continue antibiotics until resolution of infection signs, but not through complete wound healing, with typical duration of 1-2 weeks for mild infections and 2-3 weeks for moderate to severe infections 4
Reassess after 48-72 hours and narrow therapy based on culture results and clinical response 2

The most important therapy for infected wounds is adequate debridement and drainage, with antibiotics as adjunctive therapy 3, 2
Avoid prolonged antibiotic courses as they increase risk of resistance without additional benefit 6
Negative pressure wound therapy (VAC) should be temporarily discontinued during active infection until appropriate debridement and antibiotic therapy have been initiated 7

Parenteral therapy is preferred initially for all severe and many moderate infections, with a switch to oral agents when the patient is systemically well and culture results are available 4